Gevo, Inc. (GEVO) Posts Q2 Loss of 48c/Share, Wider than Views
Tweet
Share
E-mailGet Alerts GEVO Hot Sheet
Join SI Premium – FREE
Gevo, Inc. (NASDAQ: GEVO) reported Q2 loss of ($0.48), $0.10 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $15.76 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
- Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
